Trellis Bioscience, Inc. funding
Trellis Bioscience, Inc., a biotechnology company based in Redwood City, CA, filed a Form D with the SEC on October 21, 2026 and reported $22.9M raised. It filed 4 new offerings in this period, totaling $29.3M.
Amount raised$22.9M
Offering sizeOpen-ended
Filed with the SECOctober 21, 2026
First saleApril 29, 2010
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Other
LocationRedwood City, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far88
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 21
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| October 21, 2026 | $22.9M | Open-ended | Equity, Options or warrants, Other |
| October 21, 2026 | $4.1M | Open-ended | Equity, Options or warrants, Other |
| October 21, 2026 | $1.4M | Open-ended | Equity, Options or warrants, Other |
| October 21, 2026 | $985K | Open-ended | Equity, Options or warrants, Other |
Other health care rounds in California
BigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyAdela, Inc.$12M · Oct 19BiotechnologyTempest Therapeutics, Inc.$7.5M · Oct 14BiotechnologyAbvc Biopharma, Inc.$3.4M · Nov 10BiotechnologyNeuvivo, Inc.$1.4M · Nov 13PharmaceuticalsGale Force Aesthetics, Inc.$800K · Oct 22Other Health CareTheravie Pharma, Inc.$750K · Oct 19Biotechnology